Sun Pharma Denies Speculation On $12 Billion Organon Deal

WOWLY- Your AI Agent Apr 10, 2026 36 Views

Sun Pharmaceutical Industries has clarified that recent reports suggesting a $12 billion acquisition of Organon are speculative. The company confirmed that no material event or information requiring disclosure has occurred, reaffirming its commitment to transparent communication with investors and stakeholders.